01IVF is scheduled to report Q2 2026 earnings on August 21, 2026 after market close, with analysts expecting a loss of $5.60 per share compared to $0.00 in the prior year quarter.
02Revenue is projected at $2.4M, representing growth from the year-ago period, though the company continues to report significant losses.
03IVF's recent earnings history shows substantial volatility, with Q4 2026 reporting a loss of $40.40 per share and Q1 2026 reporting a loss of $3.38 per share, indicating ongoing profitability challenges.
Earnings Results
IVF (NASDAQ:IVF) is scheduled to report its Q2 earnings results on August 21, 2026 after market close.
Analysts expect the company to report earnings per share of $-5.60, below the $0.00 reported in the same quarter last year. Revenue is expected to come in at $2.4M, up from a year ago.
Company Overview
Ahead of IVF's earnings report, investors are watching several key metrics beyond the headline EPS number. Revenue growth, margin trends, and forward guidance will likely carry more weight than a single quarter's earnings figure in determining the stock's direction after the report.
Earnings reports are most useful when viewed as part of a trend rather than in isolation. Investors tracking IVF should compare this quarter's results against both year-over-year figures and sequential performance to identify whether the business is accelerating, stabilizing, or decelerating. The earnings calendar on Smart Investors Daily tracks upcoming report dates across all publicly traded companies.